财联社12月4日电,石四药集团(02005.HK)公告称, 比拉斯汀(用于荨麻疹治疗)和匹可硫酸钠(肠道清洁用药)已获国家药监局批准作为制剂原料药使用,标志其在抗过敏及消化道领域供应链地位进一步提升。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.